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Objective: To estimate the prevalence of anxiety and depression in a national
sample of patients with cystic ﬁbrosis (CF) and parent caregivers, and to evaluate
associations between these symptoms and health outcomes.
Methods: Standardized screening measures, the HADS-Anxiety, HADS-
Depression, and CES-D, were administered to CF patients 12 years of age and older
and to parent caregivers at 27 CF centers during routine visits. Data on 780 patients
and 417 mothers were analyzed using established cut-off scores.
Results: Elevated symptoms of anxiety were found in 33.9% of patients (adoles-
cents = 29.7%; adults = 36%), whereas 8.6% had elevated depression scores on the
HADS (adolescents = 2.1%; adults: 11.3%), 28.2% had elevated depression scores
on the CES-D (adolescents = 25.6%; adults = 29.9%). Among mothers, 51.4% had
elevated anxiety scores, 14.6% had elevated depression scores on the HADS and
24.4% on the CES-D. Small, but signiﬁcant correlations were found between FEV1
% pred and patients’ HADS-Depression scores (r=−.18, p< 0.001) and maternal
depression scores (r =−0.13, p< 0.05). A borderline correlation was found between
patients’ depressive symptoms and BMI (r =−0.12, p< 0.08).
Conclusions: Elevated symptoms of anxiety were found in one-third of adolescent
and adult patients and in half of parent caregivers. Elevations in depression were
not as prevalent, but ranged from 9% of patients on HADS (which excludes somatic
items) to about 28% of patients on CES-D, which assesses these symptoms (fatigue).
High depression scores on CES-D were found in 25% of mothers. Given these
prevalence rates, annual screening and referrals for those in the clinically elevated
range are recommended.
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Objective: To estimate the prevalence of anxious and depressive symptoms in
German-speaking patients with CF and in their caregivers, and to evaluate the
association to life satisfaction and physical health status.
Methods: A representative subsample of 670 German patients with CF and parental
caregivers of 564 minors with CF completed standard self-report measures of
anxiety/depression and life satisfaction. Data were compared to reference groups
from the general population. Correlations between anxiety/depression and medical
variables were calculated.
Results: Elevated anxiety scores were found in 20.6% of the patients, whereas
9.6% reported high levels of depression. Patients with CF reported more anxiety
than healthy controls, whereas the prevalence of depressive symptoms was similar
to the normative sample. Recent hemoptysis and recent diagnosis of diabetes were
associated with anxiety, whereas impaired lung function and transplant listing were
associated with depression.
Among caregivers, 37.2% showed elevated levels of anxiety, compared to only
18.9% of the general population sample. In contrast, the caregivers’ depression
scores were similar to those of the general population.
Life satisfaction was less than normal, and anxiety and depression were negatively
correlated with life satisfaction in both samples.
Conclusions: Anxiety in particular is an important issue for a large proportion
of German patients and caregivers. The risk of patients’ depression is higher
with greater impairment in pulmonary function. Annual screening of symptoms
of anxiety and depression, as well as appropriate referrals for those in the clinically
elevated range, are recommended.
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Introduction: CF patients and their caregivers are at increased risk for symptoms
of anxiety and depression.
Methods: 1543 subjects were recruited: 1101 patients and 442 caregivers, in
4 groups: patients age 12−17, patients >18, parents of children 0−11, parents of
children 12−17. The HADS was administered to assess anxiety and depression in
patients and caregivers and the CES-D only for caregivers. Best values for FEV1
and BMI in past year were recorded.
Results: Prevalence of anxiety and depression in female patients 12−17 was 6.8%
and 4.3%, respectively; males this age reported fewer symptoms: 5.6% elevated on
anxiety and 2.2% on depression. Among adult females, 21.7% reported elevated
anxiety and 6.8% depression; for adult males, 12.6% were elevated on anxiety
and 6.8% on depression. Anxiety was signiﬁcantly higher in females than males
(p< 0.05). Young children’s mothers reported 24.1% high anxiety and 10.8%
depression on a measure without somatic items (HADS); in contrast, 23.3% were
above the cut-off on CES-D which includes these items. Similar rates were reported
by mothers of adolescents (24.9% elevated on anxiety, 5.3% on HADS depression,
23.1% on CES-D). Lower rates of anxiety were reported by younger children’s
fathers, with 12.6% reporting elevated anxiety, 2.4% elevated depression on HADS
and 7.8% on CES-D. For older children’s fathers, these rates were: 12.2% anxiety,
4.1% HADS-depression and 12.2% depression on CES-D. Signiﬁcant negative
correlations were found between anxiety and FEV1% predicted in adult males but
not females and between anxiety and BMI% for adult males.
Discussion: Our results indicate a risk for symptoms of anxiety and depression in
CF population.
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Objective: To estimate the prevalence of anxiety and depression in patients with
cystic ﬁbrosis (CF) and parent caregivers in Turkey, and evaluate associations
between these symptoms and health outcomes.
Methods: Standardized screening measures, the HADS-Anxiety, HADS-
Depression, and CES-D, were administered to CF patients ages 8 to 18 years and
parent caregivers at CF centers in Turkey during routine visits. Data on 21 patients
and 77 mothers were analyzed using established cut-off scores.
Results: For children with CF, 17.6% had elevated symptoms of anxiety, 29.4%
had elevated symptoms of depression on the HADS, and 47.1% scored in the
clinical range on the CES-D (with somatic items). Among parents, 45.5% scored
above the cut-off on anxiety, 29.9% above the cut-off on depression (HADS), and
61.0% scored above the cut-off on the CES-D. No association was found between
anxious and depressive symptoms and clinical indices of health, such as pulmonary
functioning or BMI percentile.
Conclusions: A large percentage of both children with CF and parent caregivers
reported clinically elevated symptoms of anxiety and depression. Children reported
more depressive than anxious symptoms, with 1/3 of children scoring in the clinical
range. Parents also reported high levels of anxiety and depression; over 60% scoring
above the cut-off score on a measure with somatic items. Although no associations
were found between psychological symptoms and health outcomes, the sample
was too small to detect these associations. Additional data is being collected in
Turkey. Given these prevalence rates, annual screening and referrals for those in
the clinically elevated range are recommended.
